Cathie T. Chung, M.D.

Insurance Accepted

Languages Spoken

• English

Education & Training

Medical Degree

George Washington University School of Medicine

Internship(s)

University of California, San Francisco- Internal Medicine

Residency(ies)

University of California, San Francisco- Internal Medicine

Fellowship(s)

Stanford University Medical Center- Oncology

Publications & Media

• Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.

  Emens, L. A., Cruz, C., Eder, J. P., Braiteh, F., Chung, C., Tolaney, S. M., Kuter, I., Nanda, R., Cassier, P. A., Delord, J. P., Gordon, M. S., ElGabry, E., Chang, C. W., Sarkar, I., Grossman, W., O'Hear, C., Fassò, M., Molinero, L., Schmid, P.

• Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.

  Lee, L.A., Silverstein, M.J., Chung, C.T., Macdonald, H., Sanghavi, P., Epstein, M., Holmes, D.R., Silberman, H., Ye, W., Lagios, M.D.

• The role of aromatase inhibitors in early breast cancer.

  Chung, C.T., Carlson, R.W.

• Adjuvant aromatase inhibitors following tamoxifen for early-stage breast cancer in postmenopausal women: what do we really know?

  Chung, C.T., Carlson, R.W.

• Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers.

  Hurria, A., Wong, F.L., Villaluna, D., Bhatia, S., Chung, C.T., Mortimer, J., Hurvitz, S., Naeim, A

• Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.

  Hurria, A., Wong, F.L., Pal, S., Chung, C.T., Bhatia, S., Mortimer, J., Somlo, G., Hurvitz, S., Villaluna, D., Naeim, A.

• Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.

  Carlson, R.W., Theriault, R., Schurman, C.M., Rivera, E., Chung, C.T., Phan, S., Arun, B., Dice, K., Chiv, V.Y., Green, M., Valero, V.

• Inflammatory breast cancer: the road to progress.

  Chung, C.T., Martino, S.

• Impact of Multifocality and Lymph Node Metastasis on the Prognosis and Management of Microinvasive Breast Cancer.

  Kapoor, N. S., Shamonki, J., Sim, M. S., Chung, C. T., Giuliano, A. E.

• Barriers to treatment in patients with locally advanced breast cancer.

  Bourdeanu, L., Luu, T., Baker, N., Swain-Cabriales, S., Chung, C. T., Mortimer, J., Hurria, A., Helton, S., Smith, D., Ferrell, B., Juarez, G., Somlo, G.

• Age-Related Changes in Nanoparticle Albumin-Bound Paclitaxel Pharmacokinetics and Pharmacodynamics: Influence of Chronological Versus Functional Age.

  Hurria, A., Blanchard, M. S., Synold, T. W., Mortimer, J., Chung, C. T., Luu, T., Katheria, V., Rotter, A. J., Wong, C., Choi, A., Feng, T., Ramani, R., Doan, C. M., Brown, J., Somlo, G.

• Goals and objectives in the management of metastatic breast cancer.

  Chung, C.T., Carlson, R.W.